Q1 FY27 results: Revenue plunges about 82%, swings to loss
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.1 pts less than Nifty Microcap 250 and 5.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Caprolactam Chemicals board approved Q1 FY27 (June 2026) unaudited results. Revenue from operations fell sharply to Rs. 46.77 lakh from Rs. 256.47 lakh in Q1 FY26, an about 82 percent decline. The company swung to a loss after tax of Rs. 98.86 lakh versus a profit of Rs. 83.76 lakh a year ago. EPS turned negative at minus Rs. 2.15. Limited review report from Pulindra Patel and Co. was unqualified.
Sharp revenue fall and swing to loss signal weak operations in Q1; likely negative sentiment on the stock.